Overview

Compare the Properties and Characteristics of an Investigational Formulation of Lamotrigine With Placebo

Status:
Completed
Trial end date:
2008-07-18
Target enrollment:
Participant gender:
Summary
The objective of this sensory analysis study is to determine whether volunteers observe a significant difference in organoleptic properties between lamotrigine (430C78) cherry flavoured orally disintegrating tablets (ODT) and a placebo cherry flavoured orally disintegrating tablet. The aim is to assess the value of the placebo as a marketing aid, whereby physicians and patients may assess the personal acceptability of the organoleptic properties and potential convenience prior to prescription of the ODT formulation.
Phase:
Phase 1
Details
Lead Sponsor:
GlaxoSmithKline
Treatments:
Anticonvulsants
Lamotrigine